RxSight Financial Overview
RxSight's market cap is currently $494.63M. The company's EPS TTM is $-0.24; its P/E ratio is -13.93; RxSight is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
